Date: July 28 2021
Summary: How the FDA addressed concerns about drug recalls
Keywords: #food #drug #administration #omop #act #congress #sentinel #initiative #archive
EHDEN Academy
FDA thought clinical trials for drug testing was:
- Too short
- Too small scale
FDA requested observational testing of released drugs based on actual patients
US Congress passed the FDA Amendment Act
- Establishing a Risk Identification and Analysis System
- Framework to generate evidence to characterise any possible effects from drugs in use
- Utilizes observational healthcare data sources
- Sentinel Initiative created by FDA
- Surveys and studies effects of drugs on patients
Lack of regulation and drug approval guidelines after decision
- Required industry partnerships
- Culminated in the creation of the [Observational Medical Outcomes Partnership (OMOP)](https://jacobzelko.com/07282021181744-origins-omop)
Zelko, Jacob. FDA Amendment Act. https://jacobzelko.com/07282021175202-fda-risk-prevention. July 28 2021.